                </a></li></ul></div><p><strong>Figure 2.  <span>Combination therapy as well as a full course of Etanercept treatment led to reduction of histological damage in the ankle joints.</span></strong></p><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1"></a><p>Joints were harvested on day 23 after the induction of arthritis.</p>
<a id="article1.body1.sec3.sec2.fig1.caption1.p2" name="article1.body1.sec3.sec2.fig1.caption1.p2"></a><p>Formalin-fixed tissues were decalcified, and glass slides stained with H&amp;E were prepared.</p>
<a id="article1.body1.sec3.sec2.fig1.caption1.p3" name="article1.body1.sec3.sec2.fig1.caption1.p3"></a><p>Submitted tissue sections were examined by light microscopy and scored for severity of inflammation of the synovium, pannus formation, cartilage damage, bone marrow inflammation and periostal proliferation, with a maximum score of 4 per parameter.</p>
<a id="article1.body1.sec3.sec2.fig1.caption1.p4" name="article1.body1.sec3.sec2.fig1.caption1.p4"></a><p>N = 3–4 per treatment group.</p>
<a id="article1.body1.sec3.sec2.fig1.caption1.p5" name="article1.body1.sec3.sec2.fig1.caption1.p5"></a><p>H&amp;E staining is shown of one rat per treatment, representative for the whole treatment group.</p>
<a id="article1.body1.sec3.sec2.fig1.caption1.p6" name="article1.body1.sec3.sec2.fig1.caption1.p6"></a><p>A: Combination therapy; B: Etanercept 1×; C: Peptide Mt. 180-188 4× monotherapy; D: No treatment; E: Etanercept 3×.</p>
<span>THISISTHEEND
